CN120981172A - 脂肪前体细胞分化促进剂和胰岛素抵抗性改善剂 - Google Patents

脂肪前体细胞分化促进剂和胰岛素抵抗性改善剂

Info

Publication number
CN120981172A
CN120981172A CN202480014939.5A CN202480014939A CN120981172A CN 120981172 A CN120981172 A CN 120981172A CN 202480014939 A CN202480014939 A CN 202480014939A CN 120981172 A CN120981172 A CN 120981172A
Authority
CN
China
Prior art keywords
lactic acid
acid bacteria
fructobacillus
strain
insulin resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480014939.5A
Other languages
English (en)
Chinese (zh)
Inventor
时本悠司
井户垣秀聪
西川孝治
枡田优菜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osaka Soda Co Ltd
Original Assignee
Osaka Soda Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osaka Soda Co Ltd filed Critical Osaka Soda Co Ltd
Publication of CN120981172A publication Critical patent/CN120981172A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN202480014939.5A 2023-02-27 2024-02-26 脂肪前体细胞分化促进剂和胰岛素抵抗性改善剂 Pending CN120981172A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2023-028455 2023-02-27
JP2023028455 2023-02-27
JP2023140680 2023-08-31
JP2023-140680 2023-08-31
PCT/JP2024/006844 WO2024181369A1 (ja) 2023-02-27 2024-02-26 脂肪前駆細胞分化促進剤、及びインスリン抵抗性改善剤

Publications (1)

Publication Number Publication Date
CN120981172A true CN120981172A (zh) 2025-11-18

Family

ID=92590601

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480014939.5A Pending CN120981172A (zh) 2023-02-27 2024-02-26 脂肪前体细胞分化促进剂和胰岛素抵抗性改善剂

Country Status (4)

Country Link
JP (1) JPWO2024181369A1 (https=)
KR (1) KR20250156727A (https=)
CN (1) CN120981172A (https=)
WO (1) WO2024181369A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5053667B2 (ja) 2006-12-28 2012-10-17 日清ファルマ株式会社 新規乳酸菌および脂肪細胞分化促進用乳酸菌発酵産物
JP2011153093A (ja) 2010-01-27 2011-08-11 Shiseido Co Ltd 脂肪前駆細胞分化促進剤
JP2016037487A (ja) 2014-08-11 2016-03-22 一般財団法人日本食品分析センター 前駆脂肪細胞分化誘導促進剤
JP6865459B2 (ja) 2016-08-29 2021-04-28 学校法人近畿大学 インスリン抵抗性改善剤
JP6920071B2 (ja) * 2017-02-16 2021-08-18 ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ アディポネクチン分泌向上剤
JP7287948B2 (ja) * 2018-03-22 2023-06-06 オリエンタル酵母工業株式会社 多分化能性幹細胞分化促進剤
KR20230124883A (ko) * 2020-12-25 2023-08-28 가부시키가이샤 오사카소다 니코틴아미드 모노뉴클레오티드의 제조 방법

Also Published As

Publication number Publication date
KR20250156727A (ko) 2025-11-03
JPWO2024181369A1 (https=) 2024-09-06
WO2024181369A1 (ja) 2024-09-06

Similar Documents

Publication Publication Date Title
EP3357500B1 (en) Composition for preventing hair loss or promoting hair growth comprising extracellular follicle derived from lactic acid bacteria
EP2474237B1 (en) Equol-containing fermentation product of soybean embryonic axis, and method for production thereof
JP7684906B2 (ja) ニコチンアミドリボシドを産生する乳酸菌、並びにニコチンアミドモノヌクレオチド及びニコチンアミドリボシドを産生する乳酸菌
JP6535505B2 (ja) マンネンタケ抽出物を用いた幹細胞の未分化状態維持剤及び増殖促進剤
AU2019260953B2 (en) Composition for type IV allergy
JP5534747B2 (ja) アクアポリン産生促進剤
JP2020147527A (ja) ヒアルロン酸産生促進剤および保湿剤、コラーゲン産生促進剤および抗シワ剤、細胞賦活化剤、ならびに、メラニン産生抑制剤および美白剤
KR102420930B1 (ko) 미립화된 유산균 사균체를 포함하는 비만 예방 및 치료용 조성물
CN115025129B (zh) 含乳酸杆菌的组合物及其预防及/或改善皮肤老化的用途
EP4445894A1 (en) Collagen production promoter, hyaluronic acid production promoter, and epidermal keratinocyte activator
JP2023036013A (ja) ミトコンドリア機能改善剤、ミトコンドリア生合成促進剤、及びＰＧＣ１α遺伝子発現促進剤
TW202102250A (zh) 黑米萃取發酵物及其製備與應用
JP7799975B2 (ja) 皮膚バリヤ機能改善剤、及び肌状態改善剤
JP5775662B2 (ja) ヒアルロン酸合成促進剤
JP2024121821A (ja) 抗肥満剤、筋力向上剤、脂肪性肝炎改善剤、及び脂質代謝改善剤
CN120981172A (zh) 脂肪前体细胞分化促进剂和胰岛素抵抗性改善剂
JP5951077B2 (ja) ヒアルロン酸合成促進剤
JP5782534B2 (ja) アクアポリン産生促進剤
JP7627552B2 (ja) 抗糖化剤
TW202313087A (zh) 秋姬李發酵物、其製作方法和其用途
TW202444337A (zh) 合生元組合物、代謝物及其預防及治療肥胖相關疾病的用途
JP2024151772A (ja) 幹細胞増殖促進剤
JP2008179549A (ja) 糸状菌由来免疫賦活剤
JP2020171242A (ja) 幹細胞の増殖促進剤
HK1196360B (en) Method for purifying oligomeric proanthocyanidin, method for controlling degree of polymerization, hyaluronidase inhibitor, and collagenase inhibitor

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination